Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
⏸️ Investing
7 shares crushing the ASX in 2016
⏸️ Investing
3 shares at 52-week highs – is it too late to buy?
⏸️ Investing
Here's why these 4 ASX shares crashed today
⏸️ Investing
How much are Medical Developments International Ltd shares really worth?
⏸️ Investing
How to build a defensive 5 stock healthcare portfolio
⏸️ Investing
Up 50% in September, is Medical Developments International Ltd a buy?
⏸️ Investing
Medical Developments International Ltd's profit surges as global growth accelerates
⏸️ Investing
Is Medical Developments International Ltd on the path to global success?
⏸️ Investing
Morning market movers: 11 stocks to watch
⏸️ Investing
Medical Developments International Ltd – the next small-cap superstar?
⏸️ Investing
Is Medical Developments International Ltd set to post blockbuster returns?
⏸️ Investing
The ASX is sinking but these 5 stocks are soaring
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
